98 related articles for article (PubMed ID: 2414784)
1. Bepridil: a review of its pharmacology and clinical efficacy as an anti-anginal agent with anti-arrhythmic properties.
Alpert JS; Coumel P; Greeff K; Krikler DM; Remme WJ; Schönbaum E; Verduyn CW
Pharmatherapeutica; 1985; 4(4):195-222. PubMed ID: 2414784
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiological profile of bepridil, a new anti-anginal drug with calcium blocking properties.
Flammang D; Waynberger M; Jansen FH; Paillet R; Coumel P
Eur Heart J; 1983 Sep; 4(9):657-54. PubMed ID: 6605854
[TBL] [Abstract][Full Text] [Related]
3. [Electrophysiologic effects of bepridil on the human heart].
Valère PE; Belin A; Chentir T; Lehner JP; Guerot C; Tricot R
Ann Cardiol Angeiol (Paris); 1982; 31(5):409-15. PubMed ID: 6984315
[No Abstract] [Full Text] [Related]
4. [Anti-angina effect of the calcium antagonist bepridil in stable angina pectoris].
Schneider W; Mehlhorn C; Kaltenbach M; Bussmann WD
Z Kardiol; 1985 Jun; 74(6):341-7. PubMed ID: 3895761
[TBL] [Abstract][Full Text] [Related]
5. Bepridil for chronic stable angina pectoris: results of a prospective multicenter, placebo-controlled, dose-ranging study in 77 patients.
DiBianco R; Alpert J; Katz RJ; Spann J; Chesler E; Ferri DP; Larca LJ; Costello RB; Gore JM; Eisenman MJ
Am J Cardiol; 1984 Jan; 53(1):35-41. PubMed ID: 6362386
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of oral bepridil in ventricular arrhythmias in stable coronary insufficiency].
Rio A; Pasco A; Dupont T; Deroubaix G; Moulinie E; Rossignol B; Pellet J; Brechenmacher C
Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():75-8. PubMed ID: 3938263
[TBL] [Abstract][Full Text] [Related]
7. [A clinical trial of the effectiveness and tolerance of bepridil in unstable angina pectoris].
Amat G; Boch C; Curnier JM; Colonna D
Sem Hop; 1982 Dec; 58(45):2660-3. PubMed ID: 6297063
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular pharmacology of bepridil (1[3 isobutoxy 2 (benzylphenyl) amino] propyl pyrrolidine hydrochloride) a new potential anti-anginal compound.
Cosnier D; Duchenne-Marullaz P; Rispat G; Streichenberger G
Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):133-51. PubMed ID: 849059
[TBL] [Abstract][Full Text] [Related]
9. Comparative clinical efficacy of bepridil, propranolol and placebo in patients with chronic stable angina.
Rae AP; Beattie JM; Lawrie TD; Hutton I
Br J Clin Pharmacol; 1985 Mar; 19(3):343-52. PubMed ID: 3885985
[TBL] [Abstract][Full Text] [Related]
10. Bepridil block of cardiac calcium and sodium channels.
Yatani A; Brown AM; Schwartz A
J Pharmacol Exp Ther; 1986 Apr; 237(1):9-17. PubMed ID: 2420970
[TBL] [Abstract][Full Text] [Related]
11. Nicardipine, nitrendipine, and bepridil: new calcium antagonists for cardiovascular disorders.
Hasegawa GR
Clin Pharm; 1988 Feb; 7(2):97-108. PubMed ID: 3280222
[TBL] [Abstract][Full Text] [Related]
12. Bepridil.
Lancet; 1988 Feb; 1(8580):278-9. PubMed ID: 2893088
[No Abstract] [Full Text] [Related]
13. Bepridil. A review of its pharmacological properties and therapeutic use in stable angina pectoris.
Hollingshead LM; Faulds D; Fitton A
Drugs; 1992 Nov; 44(5):835-57. PubMed ID: 1280569
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic focus: bepridil].
Woler C
Ann Cardiol Angeiol (Paris); 1984; 33(4):245-6. PubMed ID: 6380383
[No Abstract] [Full Text] [Related]
15. Bepridil: a new long-acting calcium channel blocking agent.
Zeller FP; Spinler SA
Drug Intell Clin Pharm; 1987 Jun; 21(6):487-92. PubMed ID: 3301244
[TBL] [Abstract][Full Text] [Related]
16. Bepridil versus verapamil in stable angina pectoris--a controlled clinical trial.
Nielsen HK; Krusell LR; Husted SE; Pluymers RJ
Int J Cardiol; 1989 Jun; 23(3):357-64. PubMed ID: 2500401
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of clinical efficacy and tolerance of bepridil in patients with effort-induced angina pectoris].
Lai C; Pirisi R; Onnis E; Tallu B; Delogu G; Cherchi A; Arca M; Cherchi A
Cardiologia; 1985 Jul; 30(7):527-31. PubMed ID: 3914919
[No Abstract] [Full Text] [Related]
18. Supraventricular antidysrhythmic and electrophysiological effects of bepridil, a new antianginal agent.
Winslow E; Kane KA
J Cardiovasc Pharmacol; 1981; 3(4):655-67. PubMed ID: 6167797
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of supraventricular and paroxysmal ventricular tachycardia with bepridil].
Fauchier JP; Cosnay P; Néel C; Rouesnel P; Bonnet P; Quilliet L
Arch Mal Coeur Vaiss; 1985 Apr; 78(4):612-9. PubMed ID: 3923987
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular actions after intravenous and intracoronary administration of the slow channel blocker bepridil.
Verdouw PD; Scheffer MG
Arzneimittelforschung; 1984; 34(1):21-5. PubMed ID: 6608356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
